Suchergebnisse - "Xiao, Zemin"

PubPharm (7)

1

Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment : A multicenter, randomized phase II trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Pu, X. | Xiao, Z. | Li, J. | +17

2

A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer

enthalten in: British journal of cancer | 2024

von Chen, B. | Yao, W. | Li, X. | +21

3

Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer : a multicenter, single-arm, phase II study

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Xia, L. | Wang, J. | Wang, C. | +27

4

Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer : A Meta-Analysis

enthalten in: JAMA network open | 2023

von Zhou, P. | Du, Y. | Zhang, Y. | +5

5

Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression

enthalten in: Iranian journal of public health | 2023

von Chen, Z. | Xiao, Z. | Tian, W. | +2

6

Neoadjuvant osimertinib and chemotherapy for stage IIIA primary pulmonary carcinosarcoma with EGFR 19DEL mutation : A case report

enthalten in: Frontiers in oncology | 2023

von Wang, H. | Wu, Z. | Du, Y. | +10

7

Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von He, J. | Su, C. | Liang, W. | +30

1
[1]